2090-2905

Journal of Skin Cancer

Hindawi Limited

View prefix report (10.1155)

Health Score

0 Excellent

Metadata coverage

Abstract
ORCID
References
License

Extended metadata coverage

Informational — signals of interoperability and funding across the corpus. Not part of the health score.

Funding

Funder
Award / grant

Affiliation & institutional identifiers

Affiliation
ROR ID

Update policy

Update policy

Your prioritized action plan

Ordered by how many DOIs each fix touches — start here, not with every error at once.

1

Attach ORCID iDs across 103 articles

ORCID iDs strengthen author disambiguation and institutional reporting.

Medium impact103 DOIs
2

Add abstracts to 14 articles

Abstracts are what surface your work in Google Scholar, Dimensions, and OpenAlex.

Low impact14 DOIs
3

Deposit reference lists for 7 records

Deposited references power Crossref's Cited-by links between your articles and the literature.

Low impact7 DOIs

DOIs for this ISSN

Showing the top 5 of 229 DOIs, ordered by correction priority.

# Title Missing Priority Citations
1 Basal Cell Carcinoma in Asians: A Retrospective Analysis of… (10.1155/2012/741397)
Abstract ORCID
61.52 16
2 Which Are the Cells of Origin in Merkel Cell Carcinoma? (10.1155/2012/680410)
ORCID
51.89 118
3 Basal Cell Carcinomas in Gorlin Syndrome: A Review of 202 Pa… (10.1155/2011/217378)
ORCID
49.33 93
4 Worldwide Increasing Incidences of Cutaneous Malignant Melan… (10.1155/2011/858425)
ORCID
46.73 73
5 Two Distinct Pathways to Development of Squamous Cell Carcin… (10.1155/2011/951250)
ORCID
44.98 62
6 Cutaneous Squamous Cell Carcinoma of the Head and Neck (10.1155/2011/502723)
ORCID
44.45 59
7 Molecular Network Associated with MITF in Skin Melanoma Deve… (10.1155/2011/730170)
ORCID
43.90 56
8 Rising Incidence of Mucosal Melanoma of the Head and Neck in… (10.1155/2012/231693)
Abstract
43.90 56
9 Oculocutaneous Albinism and Squamous Cell Carcinoma of the S… (10.1155/2015/167847)
ORCID
43.51 54
10 Multiple Roles for VEGF in Non-Melanoma Skin Cancer: Angioge… (10.1155/2012/483439)
ORCID
43.11 52
11 Merkel Cell Carcinoma: Chemotherapy and Emerging New Therape… (10.1155/2013/327150)
ORCID
43.11 52
12 BRAF in Melanoma: Pathogenesis, Diagnosis, Inhibition, and R… (10.1155/2011/423239)
ORCID
41.33 44
13 Locally Advanced and Unresectable Cutaneous Squamous Cell Ca… (10.1155/2014/284582)
ORCID
41.09 43
14 Evaluation of the Definitions of “High-Risk” Cutaneous Squam… (10.1155/2014/154340)
ORCID
40.84 42
15 Basal Cell Carcinoma of the Head and Neck (10.1155/2011/496910)
ORCID
39.21 36
16 Uveal Melanoma (10.1155/2011/573974)
ORCID
39.21 36
17 Merkel Cell Carcinoma: The Past, the Present, and the Future (10.1155/2013/929364)
ORCID
38.91 35
18 Reconstruction of Nasal Skin Cancer Defects with Local Flaps (10.1155/2011/181093)
ORCID
38.60 34
19 Basal Cell Carcinoma: 10 Years of Experience (10.1155/2011/476362)
ORCID
38.29 33
20 Basal Cell Carcinoma: From the Molecular Understanding of th… (10.1155/2011/650258)
ORCID
38.29 33
21 Treatment of Basal Cell Carcinomas with Pulsed Dye Laser: A… (10.1155/2012/286480)
ORCID
37.63 31
22 Simulators of Squamous Cell Carcinoma of the Skin: Diagnosti… (10.1155/2013/752864)
ORCID
37.63 31
23 Topical Curcumin-Based Cream Is Equivalent to Dietary Curcum… (10.1155/2012/147863)
ORCID
37.28 30
24 Basal Cell Carcinoma of the Head and Neck Region: An Analysi… (10.1155/2012/943472)
ORCID
37.28 30
25 Neglected Basal Cell Carcinomas in the 21st Century (10.1155/2011/392151)
ORCID
36.56 28
26 A Study of Basal Cell Carcinoma in South Asians for Risk Fac… (10.1155/2014/173582)
ORCID
36.56 28
27 Induction of Human Squamous Cell-Type Carcinomas by Arsenic (10.1155/2011/454157)
ORCID
36.18 27
28 A Troubling Diagnosis of Verrucous Squamous Cell Carcinoma (… (10.1155/2011/370605)
ORCID
35.78 26
29 The Role of TGF<mml:math xmlns:mml="http://www.w3.org/1998/M… (10.1155/2012/249063)
ORCID
35.78 26
30 Latest Approved Therapies for Metastatic Melanoma: What Come… (10.1155/2013/735282)
Abstract
35.37 25
31 Interleukin-1<mml:math xmlns:mml="http://www.w3.org/1998/Mat… (10.1155/2012/393681)
ORCID
34.95 24
32 Patched Knockout Mouse Models of Basal Cell Carcinoma (10.1155/2012/907543)
ORCID
34.95 24
33 Focus on Basal Cell Carcinoma (10.1155/2011/328615)
ORCID
34.51 23
34 Inhibition of Epidermal Growth Factor Receptor and PI3K/Akt… (10.1155/2011/874571)
ORCID
34.51 23
35 Nonsurgical Treatment Options for Basal Cell Carcinoma (10.1155/2011/571734)
ORCID
34.04 22
36 Outcomes of Recurrent Head and Neck Cutaneous Squamous Cell… (10.1155/2011/972497)
ORCID
34.04 22
37 Skin Cancer Knowledge, Attitudes, and Behaviors in Collegiat… (10.1155/2014/248198)
ORCID
34.04 22
38 Practical Concerns Regarding the 7th Edition AJCC Staging Gu… (10.1155/2011/156391)
ORCID
33.06 20
39 Prognostic and Risk Factors in Patients with Locally Advance… (10.1155/2011/420796)
ORCID
33.06 20
40 Tumor Suppressor Function of CYLD in Nonmelanoma Skin Cancer (10.1155/2011/614097)
ORCID
32.53 19
41 No-Needle Jet Intradermal Aminolevulinic Acid Photodynamic T… (10.1155/2011/790509)
ORCID
32.53 19
42 The Contribution of Electron Paramagnetic Resonance to Melan… (10.1155/2011/273280)
ORCID
31.97 18
43 Nanobiotechnological Nanocapsules Containing Polyhemoglobin-… (10.1155/2012/673291)
ORCID
31.97 18
44 Histopathological Study of Skin Adnexal Tumours—Institutiona… (10.1155/2014/543756)
ORCID
31.97 18
45 Merkel Cell Carcinoma of the Head and Neck: A Single Institu… (10.1155/2013/325086)
ORCID
31.38 17
46 Pre-Treatment Deep Curettage Can Significantly Reduce Tumour… (10.1155/2011/240340)
ORCID
30.76 16
47 A Review of Radiotherapy for Merkel Cell Carcinoma of the He… (10.1155/2012/563829)
ORCID
30.76 16
48 Neurotropic Melanoma: The Management of Localised Disease (10.1155/2012/706452)
ORCID
30.76 16
49 A Clinicopathological and Immunohistochemical Correlation in… (10.1155/2014/793937)
ORCID
30.76 16
50 Targeted Therapies Compared to Dacarbazine for Treatment of… (10.1155/2015/505302)
ORCID
30.76 16